The HELP FB page has just uploaded this paper with this introduction.
CHRONIC COVID (Long COVID), SFC/ME, FM:
"THERAPEUTIC TEST" AND FIRST TREATMENT SCHEME
FOR PATIENTS WITH CHRONIC FATIGUE AND BRAIN FOG TO ASSIST THE DIAGNOSIS OF PERSISTENT CLOTS
AND HYPOPERFUSION.
https://www.researchgate.net/.../355757939_CFSME_FM...
For patients with Chronic Fatigue Syndrome, Myalgic Encephalomyelitis, Fibromyalgia, Persistent Symptoms of COVID (Chronic COVID or Long COVID), Chronic Lyme, Herpesvirus, EBV, Bartonela, Babesia, Enterovirus, HPV, Gulf War Disease, Alzheimer's and others Diseases that present Chronic Fatigue and Brain Fog.
Based on scientific publications and our clinical experience, we have argued that the main cause of Chronic Fatigue, Brain Fog and Dysautonomia symptoms is long-term endothelial dysfunction, that is, an inadequate functioning of the blood vessels, and in a A high percentage of this dysfunction is accompanied by endothelitis and the presence of persistent bioclots, which are adhered to the vascular walls and also intravascularly.
We have observed that the degree of affectation is variable, there being a correlation between the severity of fatigue and brain fog, with the presence of persistent bioclots, that is to say that, with greater symptoms and the functional disability that this entails, it is presumed that there is an increased presence of persistent bioclots.
These are then vascular diseases, in which there is often no obvious damage to the tissues, so most of the tests that are routinely requested tend to be normal, such as X-rays, CT scans and laboratory tests of routine.
In the same way, the tests to evaluate coagulation that are usually requested are generally normal, since these tests are aimed at evaluating the processes related to the formation of clots and the risk of bleeding, and what happens in Chronic COVID and Chronic Fatigue Syndrome is an inhibition of the body's Fibrinolysis System, that is, there is a problem that consists of the body not breaking down or destroying existing clots, so they persist, and this alteration is not detected with routine exams.
Before proceeding to apply the "Therapeutic Test" that we present and describe in this document, the patient must perform the following 2 analyzes:
1) DIMERO-D: it should be emphasized that this analysis does not measure the formation or the existing amount of clots, what it measures is the breakdown or fibrinolysis of the clots present in the body. So, if there are persistent clots, and the patient is not taking any medications, supplements, or foods with anticoagulant or fibrinolytic effect, the D-dimer may turn out to be normal or only slightly increased.
2) MEASUREMENT OF VENOUS BLOOD GASES: useful to know the Venous Oxygen Saturation (SvO2 or Sat vO2).
At the end of the "Therapeutic Test", which consists of taking medications or supplements with antiplatelet, anticoagulant and/ or fibrinolytic effects for 6 days, the symptoms of fatigue and brain fog, as well as the 2 aforementioned tests, should improve significantly, thus the Test result would be POSITIVE for Persistent Clots and Tissue Hypoperfusion.
If the patient could not undergo at least the D-Dimer, to interpret the result of the Test only the clinical response will be evaluated, since, if there is a significant improvement in Fatigue, Brain Fog and symptoms of Dysautonomia, it would be understood that the medications have worked by breaking down clots and these would be the cause of the symptoms.
Before taking supplements or medications with effects on clotting for several days, the risk of bleeding should be evaluated, especially in people with a history of ulcers or increased acid in the stomach and duodenum, and in older adults
Like
Comment